These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 9037338)

  • 21. Economic considerations for the hepatologist.
    Provenzale D
    Hepatology; 1999 Jun; 29(6 Suppl):13S-17S. PubMed ID: 10386077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principles of economic evaluation for health care programs.
    O'Brien B
    J Rheumatol; 1995 Jul; 22(7):1399-402. PubMed ID: 7562784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Economic aspects of prevention: an international perspective].
    Suhrcke M
    Gesundheitswesen; 2009 Oct; 71(10):610-6. PubMed ID: 19885761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On sale: future health care. The paradox of discounting.
    Ganiats TG
    West J Med; 1992 May; 156(5):550-3. PubMed ID: 1595287
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-effectiveness of drug abuse treatment for primary prevention of acquired immunodeficiency syndrome: epidemiologic considerations.
    Lampinen TM
    NIDA Res Monogr; 1991; 113():114-28. PubMed ID: 1762635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A critical review of methods for the economic evaluation of fissure sealants.
    Lewis JM; Morgan MV
    Community Dent Health; 1994 Jun; 11(2):79-82. PubMed ID: 8044715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Philosophical concerns regarding cost-effectiveness analyses.
    Weiner BK
    Med Hypotheses; 2010 Feb; 74(2):383-6. PubMed ID: 19651478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical analysis of work-site fitness programs and their postulated economic benefits.
    Shephard RJ
    Med Sci Sports Exerc; 1992 Mar; 24(3):354-70. PubMed ID: 1549031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic evaluation of telemedicine: review of the literature and research guidelines for benefit-cost analysis.
    Dávalos ME; French MT; Burdick AE; Simmons SC
    Telemed J E Health; 2009 Dec; 15(10):933-48. PubMed ID: 19954346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Economic evaluation of health interventions. Spending health money: making good choices].
    Vail S
    Krankenpfl Soins Infirm; 1996 Apr; 89(4):26-8. PubMed ID: 8715976
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-effectiveness analysis in health care.
    Emery DD; Schneiderman LJ
    Hastings Cent Rep; 1989; 19(4):8-13. PubMed ID: 2501235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foundations of cost-effectiveness analysis for health and medical practices.
    Weinstein MC; Stason WB
    N Engl J Med; 1977 Mar; 296(13):716-21. PubMed ID: 402576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Economic analysis and public health. Why does one need economic evaluation applied to diabetes? What methods does one choose: cost effectiveness, cost utility, cost benefit? Are such studies useful in terms of public health?].
    Triomphe A
    Diabete Metab; 1993 Dec; 19(5 Suppl):473-6. PubMed ID: 8206181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effective critical care: cost containment and rationing.
    Rubenfeld GD
    Semin Respir Crit Care Med; 2012 Aug; 33(4):413-20. PubMed ID: 22875388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative policy analysis and public health policy: a macro and micro view.
    Hinman AR
    Am J Prev Med; 1997; 13(1):6-11. PubMed ID: 9037336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research evaluation and policy in dental public health.
    Lipton JA
    Curr Opin Dent; 1991 Jun; 1(3):329-36. PubMed ID: 1839360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview of the effectiveness and efficiency of HIV prevention programs.
    Holtgrave DR; Qualls NL; Curran JW; Valdiserri RO; Guinan ME; Parra WC
    Public Health Rep; 1995; 110(2):134-46. PubMed ID: 7630989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indirect cost in economic evaluation: the opportunity cost of unpaid inputs.
    Posnett J; Jan S
    Health Econ; 1996; 5(1):13-23. PubMed ID: 8653189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The costs of HIV prevention strategies in developing countries.
    Söderlund N; Lavis J; Broomberg J; Mills A
    Bull World Health Organ; 1993; 71(5):595-604. PubMed ID: 8261563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Introduction to methods of economic modelling: a primer for orthopaedic surgeons and traumatologists].
    Vavken P; Dorotka R
    Z Orthop Unfall; 2009; 147(4):419-23. PubMed ID: 19771671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.